Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma

Sorafenib, a multi-tyrosine kinase inhibitor, is a standard treatment for advanced hepatocellular carcinoma (HCC). The present study was undertaken to determine whether the growth and metastasis of HCC were influenced in mice receiving sorafenib prior to implantation with tumors, and to investigate...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zhang, Qiang-Bo, Sun, Hui-Chuan, Zhang, Ke-Zhi, Jia, Qing-An, Bu, Yang, Wang, Miao, Chai, Zong-Tao, Zhang, Quan-Bao, Wang, Wen-Quan, Kong, Ling-Qun, Zhu, Xiao-dong, Lu, Lu, Wu, Wei-Zhong, Wang, Lu, Tang, Zhao-You
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568028/
https://ncbi.nlm.nih.gov/pubmed/23409093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0055945
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items